| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
9 |
/ |
2022 |
|
|
|
| |
Data sporządzenia: |
2022-08-02 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing sales of CompuFlo Epidural System to the University of Scranton for incorporation
in their Student Registered Nurse Anesthesia Curriculum
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that it has commenced sales of the CompuFlo Epidural system to the
University of Scranton in Pennsylvania, USA for incorporation into the Student Registered
Nurse Anesthesia _SRNA_ program. The mission of the University of Scranton is to educate
the students on the latest advancements in medicine to ensure the best patient and
provider experience, so they can carry these skills forward into the workplace and
throughout their careers.
The Board of Directors of the Company believes this selection reinforces the proven
clinical and safety benefits of the technology and that training the next generation
of nurse anesthetists on the use of the instrument is critical in achieving our goal
of establishing the CompuFlo Epidural system as the new standard of care in both labor
and delivery, as well as pain management.
|
|
|
RB_ASO: Commencing sales of CompuFlo Epidural System to the University of Scranton for incorporation
in their Student Registered Nurse Anesthesia Curriculum
